Cemtrex raises $2M in registered direct stock and warrant sale
Cemtrex Inc. entered into a Securities Purchase Agreement with a single accredited institutional investor for a registered direct offering generating aggregate gross proceeds of $2,000,000.
Rhea-AI Filing Summary
Cemtrex Inc. entered into a Securities Purchase Agreement with a single accredited institutional investor for a registered direct offering generating aggregate gross proceeds of $2,000,000. The transaction involved the sale of common equity and pre-funded warrants to that investor.
The offering closed on December 11, 2025, with Cemtrex issuing 310,000 shares of common stock and pre-funded warrants to purchase 356,667 additional shares of common stock. Legal counsel The Doney Law Firm delivered an opinion on the legality of the securities, and Cemtrex issued a press release describing the offering, which is included as an exhibit.
Positive
- None.
Negative
- None.
Insights
Cemtrex raises $2,000,000 through a small registered direct equity deal.
Cemtrex completed a registered direct offering with a single accredited institutional investor, bringing in gross proceeds of $2,000,000. The structure combines immediate equity issuance with additional potential shares via pre-funded warrants, a common approach for small-cap issuers to secure capital quickly.
The company issued 310,000 shares of common stock and pre-funded warrants exercisable for 356,667 shares of common stock as of December 11, 2025. This increases the potential share count, while providing immediate cash inflow. Future disclosures in company filings may provide more context on how this capital fits into Cemtrex’s broader financing strategy.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cemtrex (CETX) announce in its December 11, 2025 8-K?
How much capital did Cemtrex (CETX) raise in the registered direct offering?
Who purchased the securities in Cemtrex’s December 2025 offering?
Did the Cemtrex offering close on the same day the agreement was signed?
Which law firm provided the legal opinion for Cemtrex’s securities issuance?
Did Cemtrex issue a press release about the December 2025 offering?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4I under the Exchange Act (17 CFR 240.13I(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||
CURRENT REPORT ON FORM 8-K
Cemtrex, Inc.
Item 1.01. Entry into a Material Definitive Agreement.
On December 11, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.
The Offering closed on December 11, 2025. The Company issued 310,000 shares of common stock and prefunded warrants to purchase 356,667 shares of common stock. The Purchase Agreement contains customary representations, warranties, and covenants by the Company and the Purchaser.
The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. The Doney Law Firm, counsel to the Company, delivered an opinion as to the legality of the issuance and sale of the securities, a copy of which is attached hereto as Exhibit 5.1.
Item 8.01 Other Events.
The Company issued a press release announcing the Offering on December 11, 2025. A copy of the press release is attached hereto as Exhibit 99.1, and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit Number |
Exhibit Title | |
| 4.1 | Form of Pre-Funded Common Stock Purchase Warrant | |
| 5.1 | Opinion of The Doney Law Firm | |
| 10.1 | Securities Purchase Agreement, dated December 11, 2025 | |
| 23.1 | Consent of The Doney Law Firm (contained in Exhibit 5.1) | |
| 99.1 | Press Release dated December 11, 2025 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CEMTREX, INC. | ||
| Date: December 11, 2025 | By: | /s/ Saagar Govil |
| Saagar Govil | ||
| Chairman, President, and Chief Executive Officer | ||
| 3 |